Clinical trial
A Randomized Placebo-controlled Study to Assess Safety and Preliminary Efficacy of BGP345A in Patients With Constipation Due to the Use of Opioid-based Medications for the Management of Chronic Non Cancer Pain
NCT05133076 is registered in ClinicalTrials.gov with BioGaia Pharma AB as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Randomized Placebo-controlled Study to Assess Safety and Preliminary Efficacy of BGP345A in Patients With Constipation Due to the Use of Opioid-based Medications for the Management of Chronic Non Cancer Pain
- Lead sponsor
- BioGaia Pharma AB
- Phase
- Phase 2
- Overall status
- Completed
- Start date
- January 20, 2022
- Completion date
- December 12, 2024
- Enrollment
- 14 (actual)
- Sites
- 4
Conditions
As the registry lists them; a condition with its own page is linked.